D-0439-2026 Class II Ongoing
FDA drug recall D-0439-2026 was initiated by Fagron Compounding Services on Mar 20, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port The recall status is ongoing. Affected quantity: 5140 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 15, 2026
- Initiation Date
- Mar 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5140 bags
Product description
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02
Reason for recall
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Distribution pattern
Nationwide in the U.S.A.
Code information
Lot: C274-000050004, Exp.: 4/24/2026; C274-000050295, Exp.:5/8/2026; C274-000050773, Exp.: 6/4/2026; C274-000051219, Exp.: 6/21/2026; C274-000051318, Exp.: 6/27/2026; C274-000051602, Exp.: 7/12/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0439-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026